HLA-DRB1 and myeloid sarcoma: Although we found several HLA-DRB1*15:01 positive individuals among the MS patients wo CD206hi CD209hi Mo in line with literature regarding the MS population (45%), we observed that 75% of MS patients w CD206hi CD209hi Mo carry this susceptibility gene.